| The CHEMDNER corpus of chemicals and drugs and its annotation principles M Krallinger, O Rabal, F Leitner, M Vazquez, D Salgado, Z Lu, R Leaman, ... Journal of cheminformatics 7 (1), S2, 2015 | 336 | 2015 |
| Information retrieval and text mining technologies for chemistry M Krallinger, O Rabal, A Lourenco, J Oyarzabal, A Valencia Chemical reviews 117 (12), 7673-7761, 2017 | 272 | 2017 |
| Overview of the BioCreative VI chemical-protein interaction Track M Krallinger, O Rabal, SA Akhondi Proceedings of the BioCreative VI Workshop. Bethesda, MD, USA, 141-146, 2017 | 254 | 2017 |
| CHEMDNER: The drugs and chemical names extraction challenge M Krallinger, F Leitner, O Rabal, M Vazquez, J Oyarzabal, A Valencia Journal of cheminformatics 7 (1), S1, 2015 | 251 | 2015 |
| Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies E San José-Enériz, X Agirre, O Rabal, A Vilas-Zornoza, JA Sanchez-Arias, ... Nature communications 8, 15424, 2017 | 140 | 2017 |
| APIF: a new interaction fingerprint based on atom pairs and its application to virtual screening VI Pérez-Nueno, O Rabal, JI Borrell, J Teixidó Journal of chemical information and modeling 49 (5), 1245-1260, 2009 | 116 | 2009 |
| Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases W Link, J Oyarzabal, BG Serelde, MI Albarran, O Rabal, A Cebriá, ... Journal of Biological Chemistry, jbc. M109. 038984, 2009 | 101 | 2009 |
| Dual targeting of histone methyltransferase G9a and DNA‐methyltransferase 1 for the treatment of experimental hepatocellular carcinoma M Bárcena‐Varela, S Caruso, S Llerena, G Álvarez‐Sola, I Uriarte, ... Hepatology, 2018 | 97 | 2018 |
| A first-in-class small-molecule that acts as a dual inhibitor of HDAC and PDE5 and that rescues hippocampal synaptic impairment in Alzheimer’s disease mice M Cuadrado-Tejedor, C Garcia-Barroso, JA Sánchez-Arias, O Rabal, ... Neuropsychopharmacology 42 (2), 524, 2017 | 96 | 2017 |
| Comparison of Ligand-Based and Receptor-Based Virtual Screening of HIV Entry Inhibitors for the CXCR4 and CCR5 Receptors Using 3D Ligand Shape Matching and Ligand− Receptor Docking VI Pérez-Nueno, DW Ritchie, O Rabal, R Pascual, JI Borrell, J Teixidó Journal of chemical information and modeling 48 (3), 509-533, 2008 | 89 | 2008 |
| Design, synthesis, and biological evaluation of first-in-class dual acting histone deacetylases (HDACs) and phosphodiesterase 5 (PDE5) inhibitors for the treatment of Alzheimer … O Rabal, JA Sánchez-Arias, M Cuadrado-Tejedor, I de Miguel, ... Journal of medicinal chemistry 59 (19), 8967-9004, 2016 | 81 | 2016 |
| Overview of the chemical compound and drug name recognition (CHEMDNER) task M Krallinger, F Leitner, O Rabal, M Vazquez, J Oyarzabal, A Valencia BioCreative challenge evaluation workshop 2, 2, 2013 | 76 | 2013 |
| Overview of the CHEMDNER patents task M Krallinger, O Rabal, A Lourenco, MP Perez, GP Rodriguez, M Vazquez, ... Proceedings of the fifth BioCreative challenge evaluation workshop, 63-75, 2015 | 65 | 2015 |
| Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach J Oyarzabal, N Zarich, MI Albarran, I Palacios, M Urbano-Cuadrado, ... Journal of medicinal chemistry 53 (18), 6618-6628, 2010 | 62 | 2010 |
| Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the … O Rabal, JA Sánchez-Arias, M Cuadrado-Tejedor, I de Miguel, ... European journal of medicinal chemistry 150, 506-524, 2018 | 53 | 2018 |
| Design, synthesis and activity as acid ceramidase inhibitors of 2-oxooctanoyl and N-oleoylethanolamine analogues S Grijalvo, C Bedia, G Triola, J Casas, A Llebaria, J Teixidó, O Rabal, ... Chemistry and physics of lipids 144 (1), 69-84, 2006 | 48 | 2006 |
| In Silico Aptamer Docking Studies: From a Retrospective Validation to a Prospective Case Study'TIM3 Aptamers Binding O Rabal, F Pastor, H Villanueva, MM Soldevilla, S Hervas-Stubbs, ... Molecular Therapy-Nucleic Acids 5, 2016 | 47 | 2016 |
| Imidazo[1,2-a]pyrazines as novel PI3K inhibitors SM González, AI Hernández, C Varela, S Rodríguez-Arístegui, ... Bioorganic & medicinal chemistry letters 22 (5), 1874-1878, 2012 | 41 | 2012 |
| Discovery of reversible DNA methyltransferase and lysine methyltransferase G9a inhibitors with antitumoral in vivo efficacy O Rabal, E San José-Enériz, X Agirre, JA Sánchez-Arias, A Vilas-Zornoza, ... Journal of medicinal chemistry 61 (15), 6518-6545, 2018 | 37 | 2018 |
| Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA) MM Soldevilla, S Hervas, H Villanueva, T Lozano, O Rabal, J Oyarzabal, ... PloS one 12 (9), e0185169, 2017 | 37 | 2017 |
